Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $7,488 | 396 | 50.5% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $7,208 | 3 | 48.6% |
| Travel and Lodging | $100.63 | 2 | 0.7% |
| Education | $26.95 | 3 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Astellas Pharma US Inc | $7,472 | 12 | $0 (2024) |
| Lilly USA, LLC | $646.30 | 32 | $0 (2024) |
| ABBVIE INC. | $640.52 | 36 | $0 (2024) |
| Amgen Inc. | $527.22 | 28 | $0 (2024) |
| Novo Nordisk Inc | $508.08 | 21 | $0 (2024) |
| UCB, Inc. | $504.87 | 21 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $346.43 | 18 | $0 (2024) |
| PFIZER INC. | $289.42 | 15 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $256.73 | 19 | $0 (2018) |
| Allergan Inc. | $247.39 | 15 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,657 | 70 | Lilly USA, LLC ($302.34) |
| 2023 | $8,908 | 78 | Astellas Pharma US Inc ($7,380) |
| 2022 | $820.82 | 38 | Novo Nordisk Inc ($148.88) |
| 2021 | $161.27 | 11 | AbbVie Inc. ($28.93) |
| 2020 | $187.21 | 11 | Amgen Inc. ($38.26) |
| 2019 | $854.17 | 51 | Supernus Pharmaceuticals, Inc. ($135.96) |
| 2018 | $1,195 | 76 | Amgen Inc. ($196.30) |
| 2017 | $1,039 | 69 | AstraZeneca Pharmaceuticals LP ($151.89) |
All Payment Transactions
404 individual payment records from CMS Open Payments — Page 1 of 17
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/18/2024 | Novartis Pharmaceuticals Corporation | COSENTYX (Drug) | Food and Beverage | In-kind items and services | $31.40 | General |
| Category: Dermatology | ||||||
| 12/13/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $16.55 | General |
| Category: Neuroscience | ||||||
| 12/11/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $26.26 | General |
| Category: Rare Disease | ||||||
| 12/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $19.98 | General |
| Category: VACCINE | ||||||
| 12/06/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.72 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/25/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.55 | General |
| Category: PAIN | ||||||
| 11/15/2024 | UCB, Inc. | Rystiggo (Drug) | Food and Beverage | In-kind items and services | $24.63 | General |
| Category: Neurology | ||||||
| 11/11/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $20.65 | General |
| Category: PSYCHIATRY | ||||||
| 11/01/2024 | Lundbeck LLC | VYEPTI (Biological) | Food and Beverage | Cash or cash equivalent | $19.75 | General |
| Category: NEUROLOGY | ||||||
| 10/30/2024 | Amgen Inc. | — | Food and Beverage | In-kind items and services | $28.23 | General |
| 10/28/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $21.41 | General |
| Category: Diabetes | ||||||
| 10/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $34.69 | General |
| Category: Biological | ||||||
| 10/21/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $21.13 | General |
| Category: Oncology | ||||||
| 10/11/2024 | Genentech USA, Inc. | Evrysdi (Drug) | Food and Beverage | In-kind items and services | $27.03 | General |
| Category: Neurology | ||||||
| 10/09/2024 | Amgen Inc. | Enbrel (Biological), Otezla | Food and Beverage | In-kind items and services | $21.08 | General |
| Category: Inflammation | ||||||
| 09/24/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.79 | General |
| Category: Obesity | ||||||
| 09/18/2024 | Janssen Biotech, Inc. | TREMFYA (Drug) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Immunology | ||||||
| 09/13/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $25.42 | General |
| Category: PAIN | ||||||
| 09/12/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | Cash or cash equivalent | $124.98 | General |
| Category: Obesity | ||||||
| 08/27/2024 | Novo Nordisk Inc | Ozempic (Drug) | Food and Beverage | In-kind items and services | $17.46 | General |
| Category: Diabetes | ||||||
| 08/26/2024 | LivaNova USA, Inc. | VNS THERAPY SENTIVA MODEL 1000 GENERATOR (Device) | Food and Beverage | In-kind items and services | $24.72 | General |
| Category: Neurology | ||||||
| 08/23/2024 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $22.98 | General |
| Category: Neurology | ||||||
| 08/19/2024 | Alexion Pharmaceuticals, Inc. | ULTOMIRIS (Biological) | Food and Beverage | In-kind items and services | $24.97 | General |
| Category: Rare Disease | ||||||
| 08/16/2024 | ABBVIE INC. | UBRELVY (Drug), QULIPTA | Food and Beverage | In-kind items and services | $15.44 | General |
| Category: NEUROSCIENCE | ||||||
| 08/12/2024 | Lilly USA, LLC | EMGALITY (Drug) | Food and Beverage | In-kind items and services | $17.57 | General |
| Category: Neuroscience | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 32 | 3,569 | 4,824 | $358,841 | $136,898 |
| 2022 | 34 | 3,582 | 5,030 | $337,501 | $142,224 |
| 2021 | 34 | 3,634 | 5,068 | $303,408 | $130,634 |
| 2020 | 31 | 3,317 | 3,694 | $249,479 | $103,413 |
All Medicare Procedures & Services
131 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 267 | 267 | $61,476 | $34,606 | 56.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 274 | 331 | $68,838 | $27,703 | 40.2% |
| J0897 | Injection, denosumab, 1 mg | Office | 2023 | 11 | 723 | $30,165 | $12,994 | 43.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 145 | 200 | $29,586 | $11,934 | 40.3% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 275 | 298 | $16,630 | $4,905 | 29.5% |
| 82306 | Vitamin d-3 level | Office | 2023 | 146 | 150 | $16,596 | $4,352 | 26.2% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 299 | 328 | $19,459 | $4,303 | 22.1% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 313 | 407 | $20,260 | $4,212 | 20.8% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 50 | 50 | $4,340 | $3,440 | 79.3% |
| G0402 | Initial preventive physical examination; face-to-face visit, services limited to new beneficiary during the first 12 months of medicare enrollment | Office | 2023 | 20 | 20 | $5,898 | $3,322 | 56.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 275 | 346 | $6,806 | $2,906 | 42.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 308 | 381 | $11,510 | $2,899 | 25.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Office | 2023 | 20 | 23 | $6,675 | $2,868 | 43.0% |
| 90732 | Pneumococcal vaccine, 23-valent | Office | 2023 | 27 | 27 | $3,586 | $2,467 | 68.8% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 218 | 235 | $16,086 | $2,293 | 14.3% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 54 | 54 | $1,660 | $1,592 | 95.9% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 50 | 50 | $4,115 | $1,173 | 28.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 12 | 12 | $3,280 | $1,134 | 34.6% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 94 | 119 | $5,311 | $1,133 | 21.3% |
| 84436 | Thyroxine (thyroid chemical), total | Office | 2023 | 132 | 143 | $4,004 | $962.39 | 24.0% |
| 84479 | Thyroid hormone evaluation | Office | 2023 | 131 | 142 | $3,936 | $900.28 | 22.9% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 48 | 57 | $3,690 | $842.46 | 22.8% |
| G0009 | Administration of pneumococcal vaccine | Office | 2023 | 24 | 24 | $720.00 | $705.60 | 98.0% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 16 | 16 | $1,420 | $589.55 | 41.5% |
| 81003 | Automated urinalysis test | Office | 2023 | 224 | 249 | $4,362 | $547.80 | 12.6% |
About Dr. Lisa Lefkovits, MD
Dr. Lisa Lefkovits, MD is a Internal Medicine healthcare provider based in Marietta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2006. The National Provider Identifier (NPI) number assigned to this provider is 1962560128.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Lisa Lefkovits, MD has received a total of $14,823 in payments from pharmaceutical and medical device companies, with $1,657 received in 2024. These payments were reported across 404 transactions from 71 companies. The most common payment nature is "Food and Beverage" ($7,488).
As a Medicare-enrolled provider, Lefkovits has provided services to 14,102 Medicare beneficiaries, totaling 18,616 services with total Medicare billing of $513,170. Data is available for 4 years (2020–2023), covering 131 distinct procedure/service records.
Practice Information
- Specialty Internal Medicine
- Location Marietta, GA
- Active Since 12/04/2006
- Last Updated 12/16/2020
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1962560128
Products in Payments
- Veozah (Drug) $7,435
- Trintellix (Drug) $247.22
- FARXIGA (Drug) $244.05
- VRAYLAR (Drug) $233.88
- Aimovig (Biological) $206.23
- QULIPTA (Drug) $197.15
- EMGALITY (Drug) $194.60
- Briviact (Drug) $182.06
- KESIMPTA (Drug) $171.74
- Enbrel (Biological) $167.37
- Ozempic (Drug) $164.26
- TROKENDI XR (Drug) $160.16
- Wegovy (Drug) $152.01
- ZEPBOUND (Drug) $143.82
- VYEPTI (Biological) $142.35
- Trudhesa (Drug) $134.23
- NURTEC ODT (Drug) $133.88
- MOUNJARO (Drug) $133.81
- QSYMIA (Drug) $113.17
- INVOKANA (Drug) $105.60
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Marietta
Dr. Mohammed Abubaker, Md, MD
Internal Medicine — Payments: $404,639
Ahmed Al-Badri, Md, MD
Internal Medicine — Payments: $88,349
Dr. Amyn Hirani, M.d, M.D
Internal Medicine — Payments: $68,603
Dr. Shinoj Pattali Jayavalsan, M.d, M.D
Internal Medicine — Payments: $18,051
Dr. David Cantrell, Md, MD
Internal Medicine — Payments: $14,474
Dr. Rickey Washington, Md, MD
Internal Medicine — Payments: $12,660